PHARMACY

Allscripts sponsors EHR app-development contest

BY Alaric DeArment

CHICAGO — Electronic health records company Allscripts is sponsoring a drive to develop applications that work with the company’s Open Electronic Health Records software in order to make it easier for providers to add new apps to their workflow and improve patient outcomes.

The Open App Challenge contest, announced at the Health 2.0 conference in San Francisco earlier this week, offers $750,000 in records, with the top winner taking home $250,000. The contest specifically seeks applications designed to improve management of high-cost chronic diseases, especially those that reduce costs and improve outcomes, and innovative approaches to addressing value-based care imperatives, giving priority to apps that reduce readmission rates, improve transitions of care and enhance patient engagement.

"We want the smartest people, whether physicians, nurses, caregivers or IT professionals inside and outside the industry to use their creative energy to solve real problems in health care," Allscripts CEO Glen Tullman said. "We intend to inspire developers to start a revolution by pushing the boundaries of what information technology can do to improve quality of care for patients and also keep them healthy in the first place."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

NACDS participates in U.S. Senate Health Fair

BY Antoinette Alexander

ALEXANDRIA, Va. — The National Association of Chain Drug Stores has announced that it will participate in the annual U.S. Senate Health Fair, which will take place on Oct. 11 to 12 in the U.S. Senate Office complex on Capitol Hill in Washington, D.C.  

The U.S. Senate Health Fair will offer thousands of Senate employees — including Hill staffers, Capitol Hill Police officers and other employees — an opportunity to receive healthcare advice and care, highlighting the essential role community pharmacy plays in the healthcare delivery system.  
For the third year in a row, NACDS is coordinating an exhibit at the health fair to demonstrate the importance of the pharmacist-patient relationship and the valuable role that pharmacy plays in helping patients take their medication properly and in providing patients other important health services.  
 
Pharmacists from NACDS member companies Rite Aid and Walgreens will be on hand to provide medication therapy management services and blood pressure screenings and offer advice on questions related to medications and patient health. In addition, these companies’ pharmacists will also administer flu shots for Senate employees. NACDS member companies provide similar services at other community health fairs across the country.  
 
“We talk considerably about the important role of community pharmacy in helping patients improve their health and reduce healthcare costs. But the U.S. Senate Health Fair really takes this role and turns it into reality for Senate employees, showing them that they and the people in their states can truly benefit from the services provided by community pharmacy,” said NACDS president and CEO Steve Anderson. “We thank NACDS member companies for their participation in this year’s fair and urge Senate employees to take full advantage of this opportunity to exemplify the accessibility, services and health education that pharmacists provide.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Merck KGaA to donate $1.3 million per year to academic MS research

BY Alaric DeArment

ROCKLAND, Mass. — A German drug maker is pledging millions of dollars for multiple sclerosis research, the company’s U.S. subsidiary said Thursday.

EMD Serono, part of Darmstadt, Germany-based Merck KGaA — the different name is to avoid confusion with U.S.-based Merck — said it would award up to one million euros, or $1.3 million, each year to fund innovative research into MS by academic researchers for the Grant for Multiple Sclerosis Innovation. The announcement was made at the European Committee for Treatment and Research in Multiple Sclerosis Congress in Lyon, France, and award recipients will be announced at the ECTRIMS conference next year in Copenhagen, Denmark.

EMD Serono will give out grant money for projects in the United States and Canada, while Merck Serono will give it out for projects elsewhere.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?